Page last updated: 2024-11-07

metaraminol and Neoplasms

metaraminol has been researched along with Neoplasms in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MODELL, J1
SCHWARTZ, S1

Other Studies

1 other study available for metaraminol and Neoplasms

ArticleYear
SOME ANTAGONISTIC EFFECTS OF "HEMATOPORPHYRIN" AND PROTOPORPHYRIN IN MICE.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1964, Volume: 116

    Topics: Atropine; Chlorpheniramine; Chlorpromazine; Dinitrophenols; Edetic Acid; Hematoporphyrins; Heparin;

1964